MCS was hesitating fitting OrthoK to a patient who showed inferior corneal steepening. Her main concern was that OrthoK may induce corneal ecstasia/keratoconus in the future and whether there is a link between OrthoK and keratoconus.
Read a summary of Contact Lens Spectrum’s special edition on myopia, published in late 2019, and use the links to read the full version.
This case is not your typical astigmatic myope. There are several features to this patient that require careful consideration, including high myopia, amblyopia, myopia correction and control, and eye health management.
A clinical case of high astigmatism with myopia was discussed, where the author STW faced a myopia managing dilemma for a patient whose myopia and astigmatism exceeded the parameters of the more common forms of myopia control with contact lenses.
Announcing Part 3 of 4 of exciting updates from the 2019 biannual International Myopia Conference! You’ll find links to parts 1, 2 and 4 at the end, however read on for updates on OrthoK, MYLO and MiSight!
This is Part 3 on the Annual Association for Research in Vision and Ophthalmology 2019 (ARVO) conference summary.
Only a minimal percentage of children are likely to suffer dry eye symptoms (4%) compared to 56% in adult contact lens wearers.(1) Teens may be more likely to report contact lens related dry eye than younger children,(2) and consideration should be given to any systemic medications which could exacerbate dry eye symptoms, such as acne medications and those taken for anxiety and depression.
When it comes to contact lens corrections for young myopes, the impact of orthokeratology (OK) and multifocal soft contact lenses (MFSCL) on binocular vision is pertinent to visual comfort and understanding mechanisms of myopia progression and control.
Changing a myope from spectacle to contact lens wear can alter their binocular vision (BV) function. The myope reading through their spectacles experiences base-in prism at near, as demonstrated in the image above, which moves the image further away and decreases vergence demand.
This article groups common clinical treatments in an effort to explore what we do and don’t know regarding myopia control efficacy. It highlights the need to balance the available evidence with emerging knowledge when discussing options for myopia control with patients and their carers.
